NCT00249171View on ClinicalTrials.gov

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

February 28, 2003

Conditions
SchizophreniaPsychotic DisordersEmergency Treatment
Interventions
DRUG

risperidone

All Listed Sponsors
lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT00249171 - A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients | Biotech Hunter | Biotech Hunter